Search - tctmd.com

Displaying 1 - 20 of 43

Sort: Relevancy | Date

Presentation TCT 2024

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Presenter: Lei Song

October 30, 2024

Presentation TCT 2024

Magic Touch

Presenter: Bernardo Cortese

October 30, 2024

Presentation TCT 2024

Selution

Presenter: Simon Eccleshall

October 30, 2024

Presentation TCT 2024

Sirolimus- vs. Paclitaxel-Coated Balloons for the Treatment?of Coronary Artery Disease

Presenter: Pier Pasquale Leone

October 30, 2024

Presentation TCT 2024

TCT 506: Comparison of Healing Pattern Using Optical Coherence Tomography in Small vs Large Coronary Arteries After Sirolimus-eluting Stents Implantation

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

Presenter: Atul Abhyankar

October 30, 2024

Presentation TCT 2024

TCT 504: Comparison of Vessel Responses Following Combined Sirolimus-Eluting and Endothelial Progenitor Cell Stent and Ultra-Thin Sirolimus-Eluting Stent Implantation by Serial OCT and Coronary Angioscopy

Presenter: Atsushi Kikuchi

October 30, 2024

Presentation TCT 2024

Paclitaxel, Sirolimus, Biolimus: The Art of DCBs Selection

Presenter: Joanna Wykrzykowska

October 30, 2024

Presentation TCT 2024

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Presenter: Hongbo Yang

October 30, 2024

Presentation TCT 2024

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

Presenter: Ulf Teichgräber

October 29, 2024

Presentation TCT 2024

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

Presenter: Bernardo Cortese

October 29, 2024

Presentation TCT 2024

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

Presenter: Paulo Caramori

October 29, 2024

Presentation TCT 2024

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

Presenter: Aayush Singal

October 29, 2024

Presentation TCT 2024

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

Presenter: Shoichi Kuramitsu

October 29, 2024

Presentation TCT 2024

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

Presenter: Lei Song

October 29, 2024

Presentation TCT 2024

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

Presenter: Matthias Lutz

October 29, 2024

Presentation TCT 2024

TCT 1292: Recurrent Very Late Stent Thrombosis Due to Multiple Interstruts Hollows After First-Generation Sirolimus-Eluting Stent Implantation

Presenter: Takayuki Ishihara

October 29, 2024

Presentation TCT 2024

Current and Future Clinical Evidence of SELUTION SLR™ DEB

Presenter: Simon Eccleshall

October 29, 2024

Presentation TCT 2024

Evolution of PCI – Role and Value of Drug-Eluting Balloons

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

LIMUS as the Drug of Choice for Drug-Eluting Balloons

Presenter: Aloke Finn

October 29, 2024

Advertisement

Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis from the IRONMAN II and III Trials

Magic Touch

Selution

Sirolimus- vs. Paclitaxel-Coated Balloons for the Treatment?of Coronary Artery Disease

TCT 506: Comparison of Healing Pattern Using Optical Coherence Tomography in Small vs Large Coronary Arteries After Sirolimus-eluting Stents Implantation

TCT 507: Evaluating Vascular Response to Biodegradable Polymer-Coated Sirolimus-Eluting Stents in Patients With Diabetes Mellitus Using Optical Coherence Tomography: The OCID Study

TCT 504: Comparison of Vessel Responses Following Combined Sirolimus-Eluting and Endothelial Progenitor Cell Stent and Ultra-Thin Sirolimus-Eluting Stent Implantation by Serial OCT and Coronary Angioscopy

Paclitaxel, Sirolimus, Biolimus: The Art of DCBs Selection

3-Month Versus 12-Month Dual Antiplatelet Therapy After Implantation of the Biodegradable Polymer Firehawk Sirolimus-Eluting Coronary Stent: Primary Outcomes of the TARGET DAPT Trial

Head-to-Head Comparison of Sirolimus- Versus Paclitaxel-Coated Balloon Angioplasty in the Femoropopliteal Artery: The SIRONA Randomized Controlled Trial

TCT 432: Long-Term Outcomes of Ultrathin Struts Biodegradable Polymer Sirolimus-Eluting Stent for Percutaneous Coronary Interventions: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

TCT 430: Sirolimus-Eluting Stent With Abluminal-Only Biodegradable Polymeric Coating in the Treatment of Native Coronary Artery Lesions: Inspiron Real Life II and Latitude Trials

TCT 423: Biodegradable-Polymer Coated Sirolimus-Eluting Stents in Diabetic Patients: Insights From the S-FLEX UK II Registry

TCT 425: Impact of Coronary Lesion Complexity on 5-Year Outcomes After Bioresorbable Polymer Sirolimus-Eluting Stent Implantation: Insights From the e-ULTIMASTER Registry

TCT 372: Clinical Outcomes Following Sirolimus-Eluting Iron Bioresorbable Scaffold Implantation: One-Year Follow-Up of the Patient-Level Pooled Analysis From the IRONMAN II and III Trials

TCT 371: Post Market Study of the FANTOM Sirolimus-Eluting Bioresorbable Coronary Scaffold: Long Term Clinical Outcomes

TCT 1292: Recurrent Very Late Stent Thrombosis Due to Multiple Interstruts Hollows After First-Generation Sirolimus-Eluting Stent Implantation

Current and Future Clinical Evidence of SELUTION SLR™ DEB

Evolution of PCI – Role and Value of Drug-Eluting Balloons

LIMUS as the Drug of Choice for Drug-Eluting Balloons

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content